The Better Performance Status, the Better Outcome: Laryngeal Carcinoma Treated with Definitive Radiotherapy

Yuru-Caloglu, Vuslat; Caloglu, Murat; Turan, Fatma Nesrin; Ibis, Kamuran; Karagol, Hakan; Kocak, Zafer; Uzal, Cem
December 2008
Journal of Otolaryngology -- Head & Neck Surgery;Dec2008, Vol. 37 Issue 6, p799
Academic Journal
Purpose: To evaluate the prognostic factors affecting locoregional control (LRC) and overall survival (OS) of patients with laryngeal carcinoma who were not candidates for surgical treatment due to tumour or host factors but were treated with definitive radiotherapy (RT). Patients and Methods: Sixty-three consecutive patients, treated with definitive RT between 1999 and 2085, were retrospectively analyzed. All patients had histologically proven squamous cell carcinomas of the larynx. The median age was 62 years (range 43-83 years). Follow-up ranged from 22 days to 68 months (median 32 months). Results: The LRC rates at 2 and 5 years were 70% and 48%. The 2- and 5-year OS rates were 65% and 40%. No statistically significant relationship was found between World Health Organization performance status score (WHO PSI and age (p = .21), tumour site (p = .42], overall stage (p = .11), T stage (p = .19), and N stage (p = .69). Multivariate analyses showed that a WHO PS score ≥ 2 (p < .0001) and RT treatment time ≥ 50 days (p = .0172) significantly decreased LRC. Moreover, a WHO PS score ≥ 2 (p < ,0001), RT treatment time ≥ 50 days (p = .0138), and RT dose < 66 Gy (p = .04) were significantly negative prognostic factors on OS, Conclusion: Definitive RT, in patients with early- and more advanced-stage squamous cell carcinoma of the larynx, is an important treatment option. It is clear that patients with good pretreatment PS would get better results from definitive RT.


Related Articles

  • Clinical outcomes of weekly cisplatin chemoradiotherapy for patients with pyriform sinus cancer. Sakashita, Tomohiro; Homma, Akihiro; Hatakeyama, Hiromitsu; Furusawa, Jun; Kano, Satoshi; Mizumachi, Takatsugu; Iizuka, Satoshi; Onimaru, Rikiya; Tsuchiya, Kazuhiko; Yasuda, Koichi; Shirato, Hiroki; Fukuda, Satoshi // International Journal of Clinical Oncology;Dec2015, Vol. 20 Issue 6, p1081 

    Background: Pyriform sinus squamous cell carcinoma (SCC) has one of the worst prognoses of all upper aerodigestive tract cancers. Improving clinical outcomes for patients with hypopharyngeal SCC has been particularly challenging for head and neck surgeons and oncologists. Methods: We...

  • Significance of Laryngeal Edema after Partial Laryngectomy and Radiotherapy in Supraglottic Cancer. Öksüz, Didem Çolpan; Uzel, Ömer; Yildirim, Ayşe; Yetmen, Özlem; Şahinler, İsmet; Turkan, Sedat // Journal of Otolaryngology -- Head & Neck Surgery;Oct2008, Vol. 37 Issue 5, p681 

    Objective: To evaluate the impact of the presence of laryngeal edema on outcome and the other potential prognostic factors in patients with supraglottic larynx carcinoma treated with radiotherapy after partial laryngectomy. Design: A retrospective analysis. Setting: CerrahpaÅŸa Medical...

  • Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma. B. R. Knab; J. K. Salama; A. Solanki; K. M. Stenson; E. E. Cohen; M. E. Witt; D. J. Haraf; E. E. Vokes // Annals of Oncology;Sep2008, Vol. 19 Issue 9, p1650 

    Background: Randomized trials established chemoradiotherapy as standard treatment for advanced laryngeal cancer. Patients with large-volume T4 disease (LVT4) were excluded from these trials. The purpose of this study was to report T4 laryngeal cancer patient outcome, including those with LVT4...

  • Carcinoma Larynx in Children. Manish, Julaha; Pankaj, Chaturvedi; Prathamesh, Pai; Devendra, Chaukar; Gauri, Pantvaidya; Anil, D'Cruz // International Journal of Head & Neck Surgery;2010, Vol. 1 Issue 1, p56 

    Carcinoma of the larynx is uncommon in children 15 years of age or younger. Because of low index of suspicion, the diagnosis of childhood laryngeal carcinoma is often delayed. Other factors contributing to its delayed diagnosis are the similarity of its early symptoms to those of other benign,...

  • Is Survival Reduced for Patients with Anal Cancer Requiring Surgery after Failure of Radiation? Analysis from a Population Study Over Two Decades. KIRAN, RAVI P.; POKALA, NAVEEN; ROTTOLI, MATTEO; FAZIO, VICTOR W. // American Surgeon;Feb2009, Vol. 75 Issue 2, p163 

    Chemoradiotherapy is the standard treatment for anal cancer. Surgery is reserved for failure of therapy, but there are limited data examining outcomes after surgery. From a prospective population-based database on radiation and surgical therapy, we compare outcomes for patients with anal cancer...

  • A retrospective study of californium-252 neutron brachytherapy combined with EBRT versus 3D-CRT in the treatment of esophageal squamous cell cancer. Qifeng Wang; Tao Li; Jinyi Lang; Jie Wang; Jian Wang; Huiming Liu; Xitang Jia; Bo Liu; Wang, C.-K. Chris; Wang, Qifeng; Li, Tao; Lang, Jinyi; Wang, Jie; Wang, Jian; Liu, Huiming; Jia, Xitang; Liu, Bo // Radiation Oncology;10/24/2015, Vol. 10 Issue 1, p1 

    Background: We conducted a retrospective analysis on 884 patients who were diagnosed with esophageal squamous cell carcinoma (ESCC) and treated with either the neutron brachytherapy in combination with external beam radiotherapy (NBT + EBRT) or 3-dimensional conformal...

  • Hyperchromatic Crowded Groups in Cervical Cytology--Differing Appearances and Interpretations in Conventional and ThinPrep Preparations: A Study From the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Renshaw, Andrew A.; Mody, Dina R.; Wang, Edward; Haja, Jennifer; Colgan, Terence J. // Archives of Pathology & Laboratory Medicine;Mar2006, Vol. 130 Issue 3, p332 

    Context.—The practice of gynecologic cytology requires that high-grade squamous intraepithelial lesion (HSIL) be precisely recognized. In this regard, hyperchromatic crowded groups are known to be difficult to classify in conventional gynecologic cytology, but whether this is true in...

  • Polymorphism Arg290Arg in esophageal-cancer-related gene 1 (ECRG1) is a prognostic factor for survival in esophageal cancer. Bachmann, Kai; Shahmiri, Shanly; Kaifi, Jussuf; Schurr, Paulus; Mann, Oliver; Rawnaq, Tamina; Block, Suzette; Kalinin, Viacheslav; Izbicki, Jakob R.; Strate, Tim // Journal of Gastrointestinal Surgery;Feb2009, Vol. 13 Issue 2, p181 

    Background: Esophageal cancer is one of the most frequent cancers worldwide and is associated with poor outcome. Besides clinicopathological data, few prognostic molecular markers exist. Esophageal-cancer-related gene1 (ECRG1) short tandem repeats are associated with higher risk for...

  • Human papillomavirus 16 infection predicts poor outcome in patients with esophageal squamous cell carcinoma. Ruxing Xi; Xiaozhi Zhang; Xin Chen; Shupei Pan; Beina Hui; Li Zhang; Shenbo Fu; Xiaolong Li; Xuanwei Zhang; Tuotuo Gong; Jia Guo; Shaomin Che // OncoTargets & Therapy;2015, Vol. 8, p573 

    Background: Previous studies indicate that human papillomavirus 16 (HPV16) infection plays a pivotal role in the etiology of esophageal squamous cell carcinoma (ESCC). We aim to detect the influence of HPV16 infection on ESCC patient prognosis. Patients and methods: Immunohistochemical staining...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics